October 9, 2024: Basecamp Raises $60M for Programmable Protein Research - AI-driven biotech startup Basecamp Research secured $60 million in Series B funding to enhance its protein discovery efforts, focusing on creating next-gen medicines. Collaborating with the Broad Institute, Basecamp aims to develop programmable genetic therapies targeting diseases. The companys innovations include ZymCtrl, a protein language model for enzyme design, and BaseFold, a deep learning tool that predicts 3D protein structures more accurately than existing models. Funds will boost data collection and AI research, expanding their foundational dataset and capabilities in protein discovery.
